These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 20668933)

  • 1. New insights into the role of thyroid hormone in cardiac remodeling: time to reconsider?
    Pantos C; Mourouzis I; Cokkinos DV
    Heart Fail Rev; 2011 Jan; 16(1):79-96. PubMed ID: 20668933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyroid hormone and "cardiac metamorphosis": potential therapeutic implications.
    Pantos C; Mourouzis I; Xinaris C; Papadopoulou-Daifoti Z; Cokkinos D
    Pharmacol Ther; 2008 May; 118(2):277-94. PubMed ID: 18455802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyroid hormone as a therapeutic option for treating ischaemic heart disease: from early reperfusion to late remodelling.
    Pantos C; Mourouzis I; Cokkinos DV
    Vascul Pharmacol; 2010; 52(3-4):157-65. PubMed ID: 19951746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Translating thyroid hormone effects into clinical practice: the relevance of thyroid hormone receptor α1 in cardiac repair.
    Pantos C; Mourouzis I
    Heart Fail Rev; 2015 May; 20(3):273-82. PubMed ID: 25501869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rebuilding the post-infarcted myocardium by activating 'physiologic' hypertrophic signaling pathways: the thyroid hormone paradigm.
    Pantos C; Mourouzis I; Cokkinos DV
    Heart Fail Rev; 2010 Mar; 15(2):143-54. PubMed ID: 18773293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thyroid hormone at supra-physiological dose optimizes cardiac geometry and improves cardiac function in rats with old myocardial infarction.
    Pantos C; Mourouzis I; Tsagoulis N; Markakis K; Galanopoulos G; Roukounakis N; Perimenis P; Liappas A; Cokkinos DV
    J Physiol Pharmacol; 2009 Sep; 60(3):49-56. PubMed ID: 19826181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term thyroid hormone administration reshapes left ventricular chamber and improves cardiac function after myocardial infarction in rats.
    Pantos C; Mourouzis I; Markakis K; Tsagoulis N; Panagiotou M; Cokkinos DV
    Basic Res Cardiol; 2008 Jul; 103(4):308-18. PubMed ID: 18274800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyroid hormone and cardiac repair/regeneration: from Prometheus myth to reality?
    Pantos C; Mourouzis I; Cokkinos DV
    Can J Physiol Pharmacol; 2012 Aug; 90(8):977-87. PubMed ID: 22762197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyroid hormone receptor alpha1 downregulation in postischemic heart failure progression: the potential role of tissue hypothyroidism.
    Pantos C; Mourouzis I; Galanopoulos G; Gavra M; Perimenis P; Spanou D; Cokkinos DV
    Horm Metab Res; 2010 Sep; 42(10):718-24. PubMed ID: 20560106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyroid hormone can favorably remodel the diabetic myocardium after acute myocardial infarction.
    Kalofoutis C; Mourouzis I; Galanopoulos G; Dimopoulos A; Perimenis P; Spanou D; Cokkinos DV; Singh J; Pantos C
    Mol Cell Biochem; 2010 Dec; 345(1-2):161-9. PubMed ID: 20730619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial ROS in myocardial ischemia reperfusion and remodeling.
    Bugger H; Pfeil K
    Biochim Biophys Acta Mol Basis Dis; 2020 Jul; 1866(7):165768. PubMed ID: 32173461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroid hormones and heart failure.
    Martinez F
    Heart Fail Rev; 2016 Jul; 21(4):361-4. PubMed ID: 27098905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Posttranslational modulation of FoxO1 contributes to cardiac remodeling in post-ischemic heart failure.
    Kappel BA; Stöhr R; De Angelis L; Mavilio M; Menghini R; Federici M
    Atherosclerosis; 2016 Jun; 249():148-56. PubMed ID: 27105158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autophagy during cardiac remodeling.
    Nishida K; Otsu K
    J Mol Cell Cardiol; 2016 Jun; 95():11-8. PubMed ID: 26678624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signaling mechanisms in thyroid hormone-induced cardiac hypertrophy.
    Ojamaa K
    Vascul Pharmacol; 2010; 52(3-4):113-9. PubMed ID: 20005976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of enteral different-dose levothyroxinesodium pretreatment on serum thyroid hormone levels and myocardial ischemia-reperfusion injury.
    Yang GZ; Xue FS; Liu YY; Li HX; Liu Q; Liao X
    Perfusion; 2018 Oct; 33(7):584-592. PubMed ID: 29722287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroid hormones induce unique and potentially beneficial changes in cardiac myocyte shape in hypertensive rats near heart failure.
    Thomas TA; Kuzman JA; Anderson BE; Andersen SM; Schlenker EH; Holder MS; Gerdes AM
    Am J Physiol Heart Circ Physiol; 2005 May; 288(5):H2118-22. PubMed ID: 15604125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyroid hormone and myocardial ischaemia.
    Pantos C; Mourouzis I; Xinaris C; Cokkinos DV
    J Steroid Biochem Mol Biol; 2008 Apr; 109(3-5):314-22. PubMed ID: 18430565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Review of the Molecular Mechanisms Underlying the Development and Progression of Cardiac Remodeling.
    Schirone L; Forte M; Palmerio S; Yee D; Nocella C; Angelini F; Pagano F; Schiavon S; Bordin A; Carrizzo A; Vecchione C; Valenti V; Chimenti I; De Falco E; Sciarretta S; Frati G
    Oxid Med Cell Longev; 2017; 2017():3920195. PubMed ID: 28751931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyroid hormone attenuates cardiac remodeling and improves hemodynamics early after acute myocardial infarction in rats.
    Pantos C; Mourouzis I; Markakis K; Dimopoulos A; Xinaris C; Kokkinos AD; Panagiotou M; Cokkinos DV
    Eur J Cardiothorac Surg; 2007 Aug; 32(2):333-9. PubMed ID: 17560116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.